Both in Lab Analytical Instruments
Cytek Biosciences vs Bruker
Over the past year CTKB returned +54.1% and BRKR returned +62.9%; their daily moves had a correlation of 0.34.
CTKB +54.1% BRKR +62.9%Growth of $1, one year, split-adjusted
| Metric | CTKB | BRKR |
|---|---|---|
| Price | $6.07 | $63.04 |
| Market cap | $789.0M | $9.60B |
| Today | +1.85% | +11.58% |
| 1 month | +12.8% | +4.2% |
| 6 months | +22.9% | +49.0% |
| Year to date | +20.2% | +33.8% |
| 1 year | +54.1% | +62.9% |
| Revenue growth (YoY) | +5.6% | +5.2% |
| Gross margin | 58.9% | 49.6% |
| Net margin | −25.3% | −7.5% |
| P/E (TTM) | — | — |
| Price / sales | 3.8× | 2.7× |
| Net cash | $261.8M | -$1.64B |
| Dividend yield | — | 0.32% |
| Volatility (60d) | 50.4% | 55.5% |
| Short % of float | 3.8% | 11.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).